Abstract

Objective: Functional gastrointestinal disorders (FGIDs) encompass a range of chronic conditions of unknown etiology, including functional dyspepsia, irritable bowel syndrome, functional abdominal pain, and functional constipation. The exact pathogenic mechanisms behind tuberculosis (TB) are unclear. This study aimed to investigate whether children with previous TB are at an increased risk of developing FGIDs after completion of TB treatment.

Materials and Methods: A total of 35 patients diagnosed with TB (age range, 24 to 216 months) and 49 age- and sex-matched healthy controls were included in this retrospective study. Patients were evaluated for the presence of FGID symptoms after at least 6 months had passed after cessation of TB treatment, while the control group was assessed at the time of their first examination according to the Rome IV criteria.

Results: The overall prevalence of FGIDs was 42.9% (n=15) in the patient group versus 12.2% (n=6) in the control group. A significant difference was found between the groups in terms of the frequency of FGIDs and the diagnosis of functional abdominal pain (p = 0.001 and p < 0.001, respectively).

Conclusions: This study demonstrated a higher prevalence of FGIDs in children with a history of TB compared to healthy controls, supporting the hypothesis that FGIDs are more common in children with previous TB. Children with previous TB may be at an increased risk for FGIDs, possibly due to chronic inflammation and immune system alterations associated with TB, highlighting the need for ongoing assessment of GI health in this population.

Keywords: children, functional gastrointestinal disorders, tuberculosis

Copyright and license

Copyright © 2024 The author(s). This is an open-access article published by Aydın Pediatric Society under the terms of the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite

1.
Uygun H, Yavuz S, Erdem N, Oktay SB, Özen S, Turgut M. Does previous tuberculosis increase the risk of functional gastrointestinal disorders in children?. Trends in Pediatrics. 2024;5(4):139-145. https://doi.org/10.59213/TP.2024.181

References

  1. Boronat AC, Ferreira-Maia AP, Matijasevich A, Wang YP. Epidemiology of functional gastrointestinal disorders in children and adolescents: A systematic review. World J Gastroenterol. 2017;23:3915-27. [Crossref]
  2. Keely S, Walker MM, Marks E, Talley NJ. Immune dysregulation in the functional gastrointestinal disorders. Eur J Clin Invest. 2015;45:1350-9. [Crossref]
  3. Matricon J, Meleine M, Gelot A, et al. Review article: associations between immune activation, intestinal permeability and the irritable bowel syndrome. Aliment Pharmacol Ther. 2012;36:1009-31. [Crossref]
  4. Vanheel H, Vicario M, Vanuytsel T, et al. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut. 2014;63:262-71. [Crossref]
  5. Jilani TN, Avula A, Zafar Gondal A, et al. Active tuberculosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK513246/
  6. Aygun D, Akcakaya N, Cokugras H, Camcıoglu Y. Evaluation of clinical and laboratory characteristics of children with pulmonary and extrapulmonary tuberculosis. Medicina (Kaunas). 2019;55:428. [Crossref]
  7. Kindt S, Van Oudenhove L, Broekaert D, et al. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil. 2009;21:389-98. [Crossref]
  8. Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol. 2014;26:454-70. [Crossref]
  9. Crum NF, Lederman ER, Wallace MR. Infections associated with tumor necrosis factor-alpha antagonists. Medicine (Baltimore). 2005;84:291-302. [Crossref]
  10. Rajindrajith S, Zeevenhooven J, Devanarayana NM, Perera BJC, Benninga MA. Functional abdominal pain disorders in children. Expert Rev Gastroenterol Hepatol. 2018;12:369-90. [Crossref]
  11. American Academy of Pediatrics. Tuberculosis. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, editors. Red Book: 2024 Report of the Committee on Infectious Diseases. American Academy of Pediatrics; 2024. p. 888-920.
  12. Drain PK, Bajema KL, Dowdy D, et al. Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection. Clin Microbiol Rev. 2018;31:e00021-18. [Crossref]
  13. Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120(4):316-53.
  14. Kassinen A, Krogius-Kurikka L, Mäkivuokko H, et al. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology. 2007;133:24-33. [Crossref]
  15. Vernon-Roberts A, Alexander I, Day AS. Systematic review of pediatric functional gastrointestinal disorders (Rome IV Criteria). J Clin Med. 2021;10:5087. [Crossref]
  16. Alonso-Bermejo C, Barrio J, Fernández B, et al. Functional gastrointestinal disorders frequency by Rome IV criteria. An Pediatr (Engl Ed). 2022;96:441-7. [Crossref]
  17. Borgdorff MW, Nagelkerke NJ, Dye C, Nunn P. Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection. Int J Tuberc Lung Dis. 2000;4(2):123-32.
  18. Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One. 2015;10:e0126982. [Crossref]
  19. Drossman DA. Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV. Gastroenterology. 2016;150(6):1262-79. [Crossref]
  20. Borgaonkar MR, Ford DC, Marshall JK, Churchill E, Collins SM. The incidence of irritable bowel syndrome among community subjects with previous acute enteric infection. Dig Dis Sci. 2006;51:1026-32. [Crossref]
  21. García-Carrasco M, Mendoza-Pinto C, Munguía-Realpozo P, et al. Functional gastrointestinal disorders in women with systemic lupus erythematosus: A case-control study. Neurogastroenterol Motil. 2019;31:e13693. [Crossref]
  22. Parker S, Palsson O, Sanders DS, et al. Functional gastrointestinal disorders and associated health impairment in individuals with celiac disease. Clin Gastroenterol Hepatol. 2022;20:1315-25.e4. [Crossref]
  23. Paula H, Grover M, Halder SL, et al. Non-enteric infections, antibiotic use, and risk of development of functional gastrointestinal disorders. Neurogastroenterol Motil. 2015;27:1580-6. [Crossref]
  24. Igbokwe V, Ruby LC, Sultanli A, Bélard S. Post-tuberculosis sequelae in children and adolescents: a systematic review. Lancet Infect Dis. 2023;23:e138-50. [Crossref]